Search

everythinglearnresearchcommunity

for

Search:↓

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

Low iron levels are linked to hair loss in women.

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

Combining light therapy and microneedling shows promise for treating female hair loss.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Low iron levels may be linked to hair loss in women with chronic telogen effluvium.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

The document concludes that periocular hair disorders have various causes and treatments, and proper evaluation by specialists is important for management and prognosis.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

The investigation found no work-related causes for employee hair loss at Equifax Payment Services, and the environment was not hazardous.

Stress significantly contributes to hair loss, especially in women and those aged 31-40.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

The chapter explains common scalp conditions, including infections, infestations, and tumors.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

GLPLS is a rare skin condition with specific hair loss and skin symptoms.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Two trichoscopic patterns found in hair loss: diffuse fibrotic and androgenetic alopecia, affecting treatment choice and regrowth chances.

Some breast cancer chemotherapy can cause permanent hair loss.